Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: Population register based study

BMJ

Volumn 342, Issue 7804, 2011, Pages

  Niinimäki, Maarit ^a   Suhonen, Satu ^b   Mentula, Maarit ^c   Hemminki, Elina ^d   Heikinheimo, Oskari ^c   Gissler, Mika ^d,e  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b City of Helsinki   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; ARTICLE; BLEEDING; CHLAMYDIASIS; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INCOMPLETE ABORTION; MAJOR CLINICAL STUDY; MEDICAL ABORTION; POPULATION RESEARCH; PREGNANCY OUTCOME; PRIMIGRAVIDA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SAFETY; SURGICAL EVACUATION; SURGICAL TECHNIQUE; FINLAND; INDUCED ABORTION; PREGNANCY; PREGNANCY COMPLICATION; REGISTER; STATISTICS;

ABORTIVE AGENT; MIFEPRISTONE; MISOPROSTOL;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INCOMPLETE; ABORTION, INDUCED; ADOLESCENT; ADULT; AGE DISTRIBUTION; CHLAMYDIA INFECTIONS; FEMALE; FINLAND; HEMORRHAGE; HUMANS; INCIDENCE; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 84859008273     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2111     Document Type: Article

References (25)

1. Jones RK, Finer LB, Singh S. Characteristics of US abortion patients, 2008. Guttmacher Institute, 2010.
2. Sihvo S, Bajos N, Ducot B, Kaminski M. Women's life cycle and abortion decision in unintended pregnancies. J Epidemiol Community Health 2003;57:601-5. (Pubitemid 36930287)
3. Department ofHealth. Abortion statistics, England andWales: 2009. 2010. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/ DH-116039.
4. Socialstyrelsen. Statistics. 2010. www.socialstyrelsen.se/statistics.
5. National Institute for Health and Welfare. Induced abortions. 2010. www.stakes.fi/EN/tilastot/statisticsbytopic/reproduction/abortions.htm.
6. Niinimäki M, Pouta A, Bloigu A, Gissler M, Hemminki E, Suhonen S, et al. Immediate complications aftermedical compared with surgical termination of pregnancy. Obstet Gynecol 2010;115:660-1.
7. Phelps RH, Schaff EA, Fielding SL. Mifepristone abortion in minors. Contraception 2001;64:339-43. (Pubitemid 34143203)
8. Niinimäki M, Pouta A, Bloigu A, Gissler M, Hemminki E, Suhonen S, et al. Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy. Obstet Gynecol 2009;113:845-52.
9. Finnish Gynecological Association's Task Force. Abortion. Duodecim 2001;117:2084-94.
10. World Health Organization. International Classification of Diseases (ICD). 2010. www.who.int/classifications/icd/en/.
11. Nordic Centre for Classifications in Health Care. NCSP - the NOMESCO classification of surgical procedures. 2010. www.helsedirektoratet.no/nordclass- english/ncsp/ncsp-the-nomesco-classification-of-surgical-procedures-334824.
12. RCGP/RCOG. Induced abortion operations and their early sequelae. Joint study of the Royal College of General Practitioners and the Royal College of Obstetricians and Gynaecologists. J R Coll Gen Pract 1985;35:175-80.
13. Deneux-Tharaux C, Berg C, Bouvier-Colle MH, Gissler M, Harper M, Nannini A, et al. Underreporting of pregnancy-relatedmortality in the United States and Europe. Obstet Gynecol 2005;106:684-92.
14. National Institute for Health and Welfare. National Department of Infectious Disease Epidemiology. The statistical database of the infectious diseases register. 2010. www3.ktl.fi/.
15. Gardner MJ, Altman DG. Statistics with confidence. Confidence intervals and statistical guidelines. BMJ Publishing, 1989
16. Gissler M, Ulander VM, Hemminki E, Rasimus A. Declining induced abortion rate in Finland: data quality of the Finnish abortion register. Int J Epidemiol 1996;25:376-80. (Pubitemid 26137118)
17. Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception 2008;78:149-54.
18. Shannon C, Brothers LP, Philip NM, Winikoff B. Infection after medical abortion: a review of the literature. Contraception 2004;70:183-90.
19. Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters 2008;16(suppl 21):162-72.
20. Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database Syst Rev 2008;1:CD006714.
21. Soper DE. Pelvic inflammatory disease. Obstet Gynecol 2010;116:419-28.
22. Fjerstad M, Trussell J, Sivin I, Lichtenberg ES, Cullins V. Rates of serious infection after changes in regimens for medical abortion. N Engl J Med 2009;361:145-51.
23. Munk-Olsen T, Laursen T, Pedersen CB, Lidegaard O, Mortensen PB. Induced first-trimester abortion and risk of mental disorder. N Engl J Med 2011;364:332-9.
24. Warren JT, Harvey SM, Henderson JT. Do depression and low self-esteem follow abortion among adolescents? Evidence from a national study. Perspect Sex Reprod Health 2010;42:230-5.
25. Teal SB, Dempsey-Fanning A, Weshoff C. Predictors of acceptability of medication abortion. Contraception 2007;75:224-9. (Pubitemid 46217186)